<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30099326</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>31</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1532-3080</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>41</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Breast (Edinburgh, Scotland)</Title>                <ISOAbbreviation>Breast</ISOAbbreviation>            </Journal>            <ArticleTitle>Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies.</ArticleTitle>            <Pagination>                <MedlinePgn>151-158</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0960-9776(18)30142-5</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.breast.2018.07.011</ELocationID>            <Abstract>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the impact of subtypes and comorbidities on breast cancer (BC) relapse and survival in the heterogeneous patients of the real world.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We identified patients diagnosed with BC between January 2003 and December 2005 from six population-based Swiss cancer registries. Clinicopathologic data was completed with information on locoregional and distant relapse and date and cause of death for over 10-years. We approximated BC subtypes using grade and the immunohistochemical panel for oestrogen, progesterone and human epidermal growth factor 2 (HER2) receptor status. We studied factors affecting relapse and survival.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Luminal A-like subtype represented 46% of all newly diagnosed BC (N = 1831), followed by luminal B-like (N = 1504, 38%), triple negative (N = 436, 11%) and HER2 enriched (N = 204, 5%). We observed regional disparities in subtype prevalence that contribute to explain regional differences in survival formerly described. Disease relapse and BC specific mortality differed by subtype and were lower for luminal A like tumours than for other subtypes for any stage at diagnosis. After a median follow-up of 10.9 years, 1311 (33%) had died, half of them 647 (16%) due to another disease, showing the importance of comorbidities. Omission of systemic therapies in selected patients was not associated with poorer BC specific survival, BC subtype and life expectancy playing a role.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Information on tumour subtype is necessary for an adequate interpretation of population-based BC studies. Measures of comorbidity or frailty help in the evaluation of quality of care in the highly heterogeneous patients of the real world.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ess</LastName>                    <ForeName>Silvia M</ForeName>                    <Initials>SM</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry St. Gallen-Appenzell, Cancer League Eastern Switzerland, St. Gallen, Krebsregister St.Gallen - Appenzell. Flurhofstr. 7, 9001 St. Gallen, Switzerland. Electronic address: Silvia.ess@kssg.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Herrmann</LastName>                    <ForeName>Christian</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry St. Gallen-Appenzell, Cancer League Eastern Switzerland, St. Gallen, Krebsregister St.Gallen - Appenzell. Flurhofstr. 7, 9001 St. Gallen, Switzerland; Swiss Tropical and Public Health Institute, Basel, Krebsregister St.Gallen - Appenzell. Flurhofstr. 7, 9001 St. Gallen, Switzerland. Electronic address: Christian.herrmann@kssg.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bouchardy</LastName>                    <ForeName>Christine</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Geneva Cancer Registry, University of Geneva, Magnin Registre genevois de tumeurs Rue Michel Servet 1, 1211 Geneve, Switzerland. Electronic address: Christine.BouchardyMagnin@unige.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Neyroud</LastName>                    <ForeName>Isabelle</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Geneva Cancer Registry, University of Geneva, Magnin Registre genevois de tumeurs Rue Michel Servet 1, 1211 Geneve, Switzerland. Electronic address: isabelle.neyroud-caspar@unige.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rapiti</LastName>                    <ForeName>Elisabetta</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Geneva Cancer Registry, University of Geneva, Magnin Registre genevois de tumeurs Rue Michel Servet 1, 1211 Geneve, Switzerland. Electronic address: Elisabetta.Rapiti@unige.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Konzelmann</LastName>                    <ForeName>Isabelle</ForeName>                    <Initials>I</Initials>                    <AffiliationInfo>                        <Affiliation>Valais Cancer Registry, Observatoire valaisan de la santé, Sion, Registre valaisan de tumeurs, Avenue Grand-Champsec 64, 1950 Sion, Switzerland. Electronic address: isabelle.konzelmann@ovs.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bordoni</LastName>                    <ForeName>Andrea</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Valais Cancer Registry, Observatoire valaisan de la santé, Sion, Registre valaisan de tumeurs, Avenue Grand-Champsec 64, 1950 Sion, Switzerland. Electronic address: andrea.bordoni@ti.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ortelli</LastName>                    <ForeName>Laura</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Ticino Cancer Registry, Registro tumori del Ticino Via in Selva 24, 6601, Locarno, Switzerland. Electronic address: laura.ortelli@ti.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rohrmann</LastName>                    <ForeName>Sabine</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry of the Canton Zurich and Zug, University of Zurich, Krebsregister der Kantone Zürich und Zug Vogelsangstr. 10, 8091 Zürich, Switzerland. Electronic address: sabine.rohrmann@usz.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Frick</LastName>                    <ForeName>Harald</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry St. Gallen-Appenzell, Cancer League Eastern Switzerland, St. Gallen, Krebsregister St.Gallen - Appenzell. Flurhofstr. 7, 9001 St. Gallen, Switzerland; Institute for Pathology, Kantonsspital St. Gallen, Institut für Pathologie. Rorschacher Strasse 95, 9007 St.Gallen, Switzerland. Electronic address: Harald.Frick@kssg.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mousavi</LastName>                    <ForeName>Mohsen</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Registry St. Gallen-Appenzell, Cancer League Eastern Switzerland, St. Gallen, Krebsregister St.Gallen - Appenzell. Flurhofstr. 7, 9001 St. Gallen, Switzerland. Electronic address: Mohsen.Mousavi@kssg.ch.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Thürlimann</LastName>                    <ForeName>Beat</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Breast Cancer Centre, Kantonsspital St. Gallen, Brustzentrum St. Gallen. Rorschacher Strasse 95, 9007 St.Gallen, Switzerland. Electronic address: beat.thuerlimann@kssg.ch.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Breast</MedlineTA>            <NlmUniqueID>9213011</NlmUniqueID>            <ISSNLinking>0960-9776</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer subtypes</Keyword>            <Keyword MajorTopicYN="N">Breast cancer survival</Keyword>            <Keyword MajorTopicYN="N">Distant relapse</Keyword>            <Keyword MajorTopicYN="N">Locoregional relapse</Keyword>            <Keyword MajorTopicYN="N">Population-based study</Keyword>            <Keyword MajorTopicYN="N">Switzerland</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>19</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>11</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>14</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>13</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30099326</ArticleId>            <ArticleId IdType="pii">S0960-9776(18)30142-5</ArticleId>            <ArticleId IdType="doi">10.1016/j.breast.2018.07.011</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>